Reference:
1. Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, et al. Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels. J Pharmacol Exp Ther 2005;315:1237-46.
2. Melilli B, Piazza C, Vitale DC, Marano MR, Pecori A, Mattana P, et al. Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry. Eur J Drug Metab Pharmacokinet 2011;36:71-8.
3. Cabitza P, Randelli P. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. Eur Rev Med Pharmacol Sci 2008;12:229-35.
4. Rao R, Panghate A, Chandanwale A, Sardar I, Ghosh M, Roy M, et al. Clinical comparative study: efficacy and tolerability of tolperisone and thiocolchicoside in acute low back pain and spinal muscle spasticity. Asian Spine J 2012;6:115-22.
5. Vora A. Tolperisone. http://www.japi.org/february_2010/Article_17.pdf
Keywords:
-